ArticleTropical medicine and health2026
Neutralizing antibody evidence of dengue and chikungunya virus exposure in macaques from an urban-forest fringe in Peninsular Malaysia.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arboviruses such as dengue virus (DENV), chikungunya virus (CHIKV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV) circulate between mosquito vectors and vertebrate hosts, with non-human primates (NHPs) playing an important role in sylvatic transmission cycles. In Malaysia, frequent interactions between long-tailed macaques (Macaca fascicularis) and humans at the Universiti Kebangsaan Malaysia (UKM) Bangi campus provide an opportunity to investigate arbovirus exposure at the human-wildlife interface. Forty free-ranging macaques were sampled from five locations within the UKM Bangi campus. Serum samples were screened for neutralizing antibodies against DENV, CHIKV, ZIKV, and JEV using the 90% focus reduction neutralization test (FRNT
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.